All posts by imreal

Industry: Healthcare

The Esteemed Newport Beach Board Certified Facial Plastic Surgeon Dr. Kevin Sadati Receives the 2019 “Best Cosmetic Surgeon” in both OC Register and OC Weekly Magazines

Leave a comment


Facelift_NewportBeach

Best Cosmetic Surgeon

Best Cosmetic Surgeon 5 Years In A Row


NEWPORT BEACH, Calif. (PRWEB)

Dr. Kevin Sadati is a highly specialized facial plastic surgeon with extraordinary surgical skills. As a trained sculptor and painter, he combines his surgical understanding of the human anatomy with his artistic eye to create harmonious, natural-looking results for each patient. Dr. Sadati has made appearances on TV and media outlets across the nation describing his technique that has been coined the “Natural Lift.” Clients from around the globe travel to see Dr. Sadati for his surgical expertise. He and his surgical team provide the highest standards in patient care from the initial consultation to the conclusion of their care.

In Orange County, there is no shortage of surgeons, each with many years of training and expertise. Dr. Sadati has been picked out by the many, being voted “Best Cosmetic Surgeon” for the 5th year in a row by Orange County Register and recently OC Weekly.

Dr. Sadati stated, “This is a great honor and means, even more, coming from my patients,” he continues, “the entire team at The Gallery of Cosmetic Surgery & Aesthetic Lounge strives to give patients the highest quality of care and superior results. I want to thank not only my patients but also my amazing staff for these awards.”

Dr. Sadati is known for creating natural, beautiful results. He has performed over 3,500 facial rejuvenation procedures using local anesthesia and twilight sedation without the need for general anesthesia. He utilizes his nationally recognized facelift technique called, “Triple-C Plication.” This breakthrough muscle tightening method is used for lower face and neck rejuvenation. His technique was published in the American Journal of Cosmetic Surgery, and he continues to share his expertise at plastic surgery conferences around the nation. He performs all of his surgeries in his state-of-the-art surgical facility to ensure patients have a safe and comfortable environment.

Dr. Sadati makes sure that his practice is patient-centric. During a consultation, he carefully listens to his patients and takes the time to answer their questions, help set realistic goals, and formulate a custom plan for their needs. His patients trust his skill and honesty, which is why he has been voted by Locale Magazine Readers, “Best Plastic Surgeon in Orange County,” and his colleagues have voted him as the, “Best Overall Facial Rejuvenation,” and, “Best Aesthetic Doctor,” at the Aesthetic Show. He has appeared on “The Doctors” TV show by NBC for his outstanding nasal surgical procedures and has swept the nation with his facial rejuvenation techniques.

Along with being a plastic surgeon, Dr. Sadati is an artist. His skills as a painter and sculptor have helped him fine-tune the details of his subject and has allowed for amazing surgical results and aesthetic harmony. His practice is named, “The Gallery of Cosmetic Surgery & Aesthetic Lounge,” as a testament to his love of art and his vision for his practice. Dr. Sadati provides patients with surgical services in his state-of-the-art surgical facility downstairs and has his staff of industry leaders offering non-surgical facial and body rejuvenation in the Aesthetic Lounge, his luxury medical spa on the second floor. Dr. Sadati said, “for our patients who are not candidates for surgery, or those who need to maintain their surgical results, we offer non-surgical facial and body contouring options at the Aesthetic Lounge.” Such options include micro-needling with radiofrequency, fillers, laser resurfacing, and body contouring devices like CoolTone and CoolSculpting.

For more information on Dr. Sadati and his Newport Beach practice at the Gallery of Cosmetic Surgery, visit https://galleryofcosmeticsurgery.com

Gallery of Cosmetic Surgery & Aesthetic Lounge

359 San Miguel Dr #200

Newport Beach, CA 92660

(949) 441-1447

Share article on social media or email:

Business: Executives

Torigen Pharmaceuticals Expands Leadership Team with Addition of Two Animal Health Industry Veterans

Leave a comment


News Image


FARMINGTON, Conn. (PRWEB)

Torigen Pharmaceuticals Inc., a commercial-stage companion animal immuno-oncology company, today announced the addition of two deeply experienced animal health executives to the management team to help lead the company’s next phase of growth. Michael Lucroy, DVM, MS, DACVIM (Oncology), joins as vice president of oncology business development, and Blake Hawley, DVM, MBA, has been appointed to the board of directors. Drs. Lucroy and Hawley will harness their deep understanding of the animal health industry and leverage their collective business development experience to help move Torigen forward.

“Drs. Lucroy and Hawley join us at a pivotal time in building out the business as we expand beyond our current offerings to maximizing the impact we have on pets with cancer,” said Ashley Kalinauskas, CEO, Torigen. “During the past six months, Torigen’s U.S. autologous cancer vaccine treatments have increased by an average of more than 40 percent per month, as compared with last year. Our newly formed team is poised to accelerate this growth while fulfilling our mission of making personalized cancer treatment accessible for pet owners and veterinarians.”

Dr. Lucroy joins Torigen from MedVet, where, for the past several years, he was director of the Clinical Studies Center, leading research efforts across the 24-hospital organization. Prior to his role at MedVet, he spent four years in technology acquisitions at Elanco Animal Health and served on the faculties of Oklahoma State University and Purdue University. In assuming this newly created role at Torigen, Dr. Lucroy will be responsible for analyzing current data sets, identifying new therapeutic options and managing national immuno-oncology educational programs.

Dr. Hawley, a leader and innovative entrepreneur in the animal health space, is the founder and CEO of Motega Holdings Inc. (dba Motega Health), a joint venture with Shear-Kershman Laboratories, a 40-year pioneer in the food, pharma and nutraceutical space. Previously, Dr. Hawley served as the president and CEO for an Australian-founded startup, consultant for Jaguar Animal Health and chief commercial officer for Kindred Biosciences. Dr. Hawley has also held various senior management roles at Hill’s Pet Nutrition, a division of Colgate-Palmolive, working across 23 countries and three continents.

“Torigen’s core focus is educating veterinarians on the growing field of immuno-oncology,” said Dr. Lucroy. “The clinical oncology space is seeking alternative treatment options that are safe, effective and affordable. I’m excited to bring new clinical data to the industry while identifying new opportunities to create a commercialization pipeline. As a small, nimble startup, this company can move quickly.”

Cancer is the number-one cause of death in dogs over the age of two. One in four dogs will be impacted by cancer in their lifetimes. Torigen offers exciting potential for pets with cancer through its Autologous Prescription Product, which stimulates an immune response that targets and destroys the cancer cells specific to the patient.

“Torigen is putting together one of the top teams in the animal health industry today,” said Dr. Hawley. “I’m looking forward to contributing to the board of directors and expect it will provide an opportunity for me to help mold and shape this company to become an industry leader in this critically important field of study.”

Experimental autologous cancer vaccines created by Torigen Pharmaceuticals Inc. are regulated by the USDA Center for Veterinary Biologics. Torigen’s Autologous Prescription Product should be used under supervision/prescription of a licensed veterinarian. Safety and efficacy have not been established.

For more information, email info@torigen.com, visit http://www.torigen.com or call 860-519-9956.

About Torigen Pharmaceuticals Inc.

Torigen Pharmaceuticals Inc. is focused on delivering affordable companion animal immuno-oncology products. Its initial patented product line utilizes a portion of the pet patient’s tumor to create a personalized cancer vaccine. With over 10 years of supporting pre-clinical publications, the Torigen team is focused on developing innovative veterinary cancer biologics that allow for the body to recognize foreign tumor-associated antigens and facilitate the reversal of immune senescence. For more information, please visit http://www.torigen.com.

Share article on social media or email:

Health

Mount Sinai Medical-Legal Partnership Expands Legal Services for Neediest Patients

Leave a comment



NEW YORK (PRWEB)

Mount Sinai Medical-Legal Partnership (MSMLP), an organization formed to address the legal needs of Mount Sinai’s neediest patients, unveiled two initiatives that provide free special education law and advocacy assistance to families and patients in need. The announcement was made at an event held Wednesday at Mount Sinai that also honored the work of contributions of Blaine (“Fin”) Fogg, who was a member of the Boards of Trustees of the Mount Sinai Health System.

Cyrus Vance Jr., the Manhattan District Attorney and keynote speaker, commended the efforts to provide legal assistance to patients and families in need. The Manhattan DA’s Criminal Justice Investment Initiative awarded funds to The Legal Aid Society to support two full-time Legal Aid attorneys to provide free legal services for patients at Mount Sinai St. Luke’s Child and Family Services. These attorneys will help patients and their families navigate the special education system.

“The role of law enforcement in the twenty-first century is not merely to arrest and prosecute,” said Mr. Vance. “We can deliver greater public safety and healthier communities if we prevent young people from coming into contact with the justice system in the first place. This is why, through our Criminal Justice Investment Initiative, we have partnered with Mount Sinai, The Legal Aid Society, and other leading organizations to provide the services and support necessary to help disadvantaged children and families succeed. I applaud the Mount Sinai Medical-Legal Partnership’s commitment to assisting New York’s most vulnerable through its new education law and advocacy services.”

The program provides legal services for families, education advocacy for parents and legal guardians, training for social workers and case managers, advocating special education services in schools, and representing youth in suspension hearings. Since 2016, this grant has enabled the Legal Aid Society to help approximately 200 students.

MSMLP also announced the pediatric legal clinic at The Mount Sinai Hospital, a new initiative made possible through philanthropic support that will identify and address the unmet legal needs of low-income pediatric patients and their families. This is a group with substantial unmet needs that can have lifelong consequences.

“We look at the needs of Mount Sinai patients in a holistic manner and believe that if we can work within the legal system to help demolish barriers to education as well as to housing, personal safety, immigration, and access to health care, it will materially improve the health of our patients and the community we serve,” said Barbara Berger Opotowsky, President of MSMLP.

At Wednesday’s event, Mount Sinai paid tribute to Mr. Fogg, a member of Mount Sinai Boards of Trustees for three decades and former chair of the Legal Committee. He was President of The Legal Aid Society of New York until his death this July.

“Mr. Fogg’s commitment to service inspired the formation of the MSMLP. And, I have no doubt that the legacy of that commitment will continue to inspire the lawyers and others who work with the MSMLP for many years to come,” said Beth Essig, Executive Vice President and General Counsel, Mount Sinai Health System.

Recognizing that health care alone is often not enough to make patients well, and that some patients have legal needs that materially affect their health, MSMLP works with legal services providers, law firms, Medicaid managed care companies, and law students to try to meet those needs.

MSMLP, an independent charity, launched in 2016 and works with lawyers from The Legal Aid Society, the LegalHealth and the LGBTQ divisions of the New York Legal Assistance Group, Transcend Legal, and Youth Represent, as well as with dedicated lawyers from the New York City Bar Justice Center and New York City law firms Duane Morris LLP, Hughes Hubbard & Reed LLP, Jenner & Block LLP, Latham & Watkins LLP, Schulte, Roth & Zabel LLP, and Wachtell, Lipton, Rosen & Katz.

In addition to the program at Mount Sinai St. Luke’s Child and Family Services, MSMLP has programs that provide legal help to patients throughout the Mount Sinai Health System including clinical programs such as Mount Sinai Center for Transgender Medicine and Surgery and Palliative Care Services at Mount Sinai.

About the Mount Sinai Health System

The Mount Sinai Health System is New York City’s largest integrated delivery system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai’s vision is to produce the safest care, the highest quality, the highest satisfaction, the best access and the best value of any health system in the nation. The Health System includes approximately 7,480 primary and specialty care physicians; 11 joint-venture ambulatory surgery centers; more than 410 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. The Icahn School of Medicine is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report’s “Best Medical Schools”, aligned with a U.S. News & World Report’s “Honor Roll” Hospital, No. 12 in the nation for National Institutes of Health funding, and among the top 10 most innovative research institutions as ranked by the journal Nature in its Nature Innovation Index. This reflects a special level of excellence in education, clinical practice, and research. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report’s “Honor Roll” of top U.S. hospitals; it is one of the nation’s top 20 hospitals in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Geriatrics, Gynecology, Nephrology, Neurology/Neurosurgery, and Orthopedics in the 2019-2020 “Best Hospitals” issue. Mount Sinai’s Kravis Children’s Hospital also is ranked nationally in five out of ten pediatric specialties by U.S. News & World Report. The New York Eye and Ear Infirmary of Mount Sinai is ranked 12th nationally for Ophthalmology, Mount Sinai St. Lukes and Mount Sinai West are ranked 23rd nationally for Nephrology and 25th for Diabetes/Endocrinology, and Mount Sinai South Nassau is ranked 35th nationally for Urology. Mount Sinai Beth Israel, Mount Sinai St. Luke’s, Mount Sinai West, and Mount Sinai South Nassau are ranked regionally.

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

Industry: Healthcare

Boekel Scientific has been awarded standards compliance for six blood banking devices from AABB (formerly known as the American Association of Blood Banks)

Leave a comment


As a US based manufacturer of medical devices, Boekel Scientific has strategically increased the product line breadth by collaborating with the blood banking industry. – Brian Canna, VP of Marketing


FEASTERVILLE, Pa. (PRWEB)

Compliance Notification:

Boekel Scientific has been awarded standards compliance for six blood banking devices from AABB (formerly known as the American Association of Blood Banks). The AABB Standards-Compliant Product Evaluation (SCoPE) Program, an initiative to determine vendor product compliance, was recently launched to evaluate blood banking equipment and supplies. The program was designed to drive consistency and performance in the highly regulated market. The devices are used in blood banks for thawing, storing, and collecting blood and blood products.

Boekel Scientific, a US based manufacturer of medical and laboratory devices, has been awarded standards compliance for the following equipment:

1) Small Platelet Agitator – Part Numbers 301200 / 301200-2

Product Link: https://www.boekelsci.com/small-platelet-incubator-and-agitator.html

2) Small Platelet Incubator – Part Numbers 301550 / 301550-2

Product Link: https://www.boekelsci.com/small-platelet-incubator-and-agitator.html

3) Large Platelet Agitator – Part Numbers 301300 / 301300-2

Product Link: https://www.boekelsci.com/large-platelet-incubator-and-agitator.html

4) Large Platelet Incubator – Part Numbers 301650 / 301650-2

Product Link: https://www.boekelsci.com/large-platelet-incubator-and-agitator.html

5) Plasma Thawer – Part Number 301000

Product Link: https://www.boekelsci.com/plasma-thawer-320.html

6) Blood Collection Mixer / Scale – Part Number 302000

Product Link: https://www.boekelsci.com/touch-screen-blood-collection-mixer.html

Boekel Scientific is an ISO 13495 certified medical device company that specializes in manufacturing blood banking, histology, and microbiology equipment. For more information on these devices please contact Boekel Scientific at (800) 336-6929 or visit our website at https://www.boekelsci.com. For company updates visit the Boekel Scientific LinkedIn page https://www.linkedin.com/company/boekel-scientific. For business development or marketing opportunities please contact Brian Canna, VP of Marketing at Boekel Scientific.

Share article on social media or email:

Business: Executives

Bull Springs Skyline Forest Adjacent to Bend, Oregon For Sale

Leave a comment


Bull Springs Skyline Forest Map

Once you lay eyes on Bull Springs Skyline Forest, you will agree that it is unquestionably one of the most beautiful blocks of contiguous timberland, not only in Oregon, but, in the entire western United States


BEND, Ore. (PRWEB)

Bull Springs Skyline Forest, located just minutes west of Bend is an active privately held tree farm and recreational wilderness covering 32,995+/- contiguous, deeded acres bordering the Deschutes National Forest. The property has significant long-term appreciation potential with opportunity for sustainable timber management, conservation, abundant recreation, in combination with residential and mixed-use development.

“Once you lay eyes on Bull Springs Skyline Forest, you will agree that it is unquestionably one of the most beautiful blocks of contiguous timberland, not only in Oregon, but, in the entire western United States,” said Robb Van Pelt, founding partner of Mason & Morse Ranch Company.

The property has a long history of stewardship dating back to 1916 when Shevlin-Hixon and Brooks-Scanlon opened their logging camps for production. The first Shevlin-Hixon Logging camp was placed at Bull Springs, which was active until 1946. Since that time the forest has been owned by a variety logging companies and portions exchanged with the U.S. Forest Service. In recent years, the property has become of major interest to the surrounding community of Bend, Oregon, conservation groups, land planners and developers who are interested in working together to balance its valuable attributes that ascend across private ownership, forest management, community recreation, government legislation and the westerly urban expansion of Bend, Oregon.

The current zoning is F1 Forest Use. The Deschutes County F1 Forest Use Zone is intended to conserve forestlands with a minimum 240-acre parcel size. Potentially rezoning through Oregon’s Destination Resort designation as a cluster development has become a popular balance between sustainable forest management, recreational open space, and urban expansion.

F1 Forest Use Zone permitted uses include forest operations or forest practices, provisions for wildlife and fishery resources, and other farm uses. Conditional uses permitted include private hunting and fishing, private parks and campgrounds and single-family dwellings.

Bull Springs Skyline Forest combines productive timberlands, conservation and development opportunities together with privacy. The property is one of the largest contiguous parcels in the western united states with stunning views and abundant wildlife just minutes from Bend, Oregon. When you combine the resources of timber, wildlife, water, recreation, conservation and redevelopment potential together with its close proximity to Bend, Oregon, you will find it is truly “One of a Kind.”

“Mason & Morse Ranch Company has been fortunate enough to list and sell some of the finest American farms, ranches and recreational lands across the country,” said Bart Miller, Managing Broker of Mason & Morse Ranch Company. “Bull Springs Skyline Forest is one of America’s legacy properties without question. We want to find the right buyer who recognizes the property’s attributes and values the history of the property in the community.”

About Mason & Morse Ranch Company

A leading provider of land brokerage services across the American west. Services include traditional brokerage and auction. With roots dating back to 1961 in the Roaring Fork Valley near Aspen, Colorado, the company specializes in marketing high-value and large acreage farm, ranch and recreational land properties. Combined, Mason & Morse Ranch Company agents offer clients more than 133 years of experience in real estate land sales. http://www.ranchland.com 1-877-207-9700

Share article on social media or email:

Health

Early Diagnosis, Prompt Treatment Offer Hope for Those With Rare Form of Pulmonary Hypertension Called CTEPH

Leave a comment


News Image


SILVER SPRING, Md. (PRWEB)

As part of Pulmonary Hypertension Awareness Month, on Nov. 13, the Pulmonary Hypertension Association (PHA) sets aside a day to help raise awareness and improve diagnosis of a rare form of pulmonary hypertension (PH) known as chronic thromboembolic pulmonary hypertension (CTEPH). Unlike some forms of PH, CTEPH has several treatment options, including a potentially curative surgery.

CTEPH is a form of pulmonary hypertension caused by old blood clots in the lungs. Some patients with CTEPH also have other changes in their pulmonary arteries that can make them narrower and stiffer. CTEPH stops or slows blood from flowing through the arteries and causes the right side of the heart to pump much harder, which can lead to right-heart failure and death. Symptoms include shortness of breath, fatigue and chest pain. Because these symptoms are similar to other common illnesses such as asthma, people can go months and years without a proper diagnosis.

To accurately diagnose CTEPH, doctors must incorporate a number of tests, including a right heart catheterization to measure blood pressure in the heart and lungs and a ventilation-perfusion (V/Q) scan that highlights how blood circulates through the lungs in order to locate blockages. Although CTEPH is a serious condition, the good news is that advances in treatment offer surgical and treatment options. One of these is a surgery that removes the chronic blood clots from the lungs.

“If left untreated, CTEPH is a deadly condition. Fortunately, it is perhaps the most treatable form of pulmonary hypertension where even a cure is oftentimes possible,” says Gustavo Heresi, M.D., a pulmonologist at Cleveland Clinic.

PHA will host a Facebook Live event at http://www.Facebook.com/PulmonaryHypertensionAssociation on CTEPH Awareness Day:

CTEPH Awareness Day will also feature inspiring stories by individuals with CTEPH through PHA’s “PHaces of Hope” campaign, which involves a community of individuals with PH, caregivers and health care professionals who share what gives them hope while facing this disease.

For resources on CTEPH Awareness Day, visit PHAssociation.org/CTEPHDay. The day’s activities can also be followed on social media using #CTEPHDay.

PHA’s CTEPH Awareness Day campaign is supported by a sponsorship from Bayer.

About the Pulmonary Hypertension Association

Headquartered in Silver Spring, Md., the Pulmonary Hypertension Association (PHA) is the country’s oldest and largest nonprofit patient association dedicated to the pulmonary hypertension (PH) community. Pulmonary hypertension is a rare, chronic and life-threatening disease of the lungs for which no cure currently exists. PHA’s mission is to extend and improve the lives of those affected by PH. To achieve this mission, PHA engages people with PH and their families, caregivers, health care providers, and researchers worldwide who work together to advocate for the PH community, provide support to patients, caregivers and families, offer up-to-date education and information on PH, improve quality patient care, and fund and promote research. For more information, visit http://www.PHAssociation.org and connect with PHA on Twitter, Instagram and Facebook.

Share article on social media or email:



Industry: Healthcare

StageBio and Alizée Pathology join forces to meet the growing demand for high-quality histopathology and medical device services in the preclinical services market

Leave a comment


“The broad client base and services at StageBio, combined with the specialty expertise at Alizée, are a winning combination for our clients.” – Dr. Serge Rousselle, Co-Founder, Alizée Pathology


THURMONT, Md. (PRWEB)

StageBio has merged with Alizée Pathology to form the leading provider of specialized histology, pathology, biomarker development, and archiving services for the biopharmaceutical, medical device and contract research industries. StageBio was recently created by the mergers of Histo-Scientific Research Laboratories (HSRL), Vet Path Services (VPS) and Tox Path Specialists (TPS), and now includes Alizée Pathology. StageBio is a portfolio company of Ampersand Capital Partners.

“Dr. Serge Rousselle, Dr. Joan Wicks and the Alizée staff bring unique histopathology capabilities to StageBio. These services enable us to offer the industry an even broader range of highly specialized histopathology and imaging services,” said Mr. Thomas Galati, StageBio CEO. “We have successfully merged HSRL, VPS and TPS, and are excited to add Alizée’s expertise to our growing list of offerings.”

Dr. Serge Rousselle, Co-Founder of Alizée Pathology, commented, “StageBio and Alizée have been working closely for years, and this union is a natural evolution of that relationship. The broad client base and services at StageBio, combined with the specialty expertise at Alizée, are a winning combination for our clients.” The merger adds laboratory space in Thurmont and Cumberland MD, as well as staff with experience in specialty medical devices and biomarkers/biologics that will complement the StageBio team based in Virginia, Massachusetts, Ohio, and Maryland. The combined company now employs 28 board-certified (ACVP) Veterinary Pathologists with a total employee base of over 150.

About StageBio

StageBio is the leading provider of GLP-compliant research and preclinical histology, pathology and specimen archiving services for the biopharmaceutical, medical device and contract research industries. We provide our customers with a fully integrated breadth of histopathology services, including tissue analysis, efficacy determination for new compounds and devices, toxicological evaluation of products subject to FDA approval, detailed pathology reporting for GLP studies, medical device pathology and immunohistochemistry. We operate numerous state-of-the-art sites in Virginia, Massachusetts, Ohio, and Maryland, with substantial continued investment in our facility and technology infrastructures to meet the growing demand for high-quality histopathology services. We are ideally positioned to deliver on our unified commitment to quality, scientific integrity and customer service excellence. Additional information about StageBio is available at http://www.stagebio.com.

About Alizée Pathology

Founded in 2010, Alizée Pathology is one of the leading preclinical medical device laboratories in North America. Founded and led by Drs. Serge Rousselle and Joan Wicks, Alizée provides GLP-compliant services in support of the development of novel devices and therapeutics. Alizée’s team is comprised of ACVP boarded Pathologists, PhDs, MDs and highly trained scientists who are focused on delivering clear, reproducible, and contextual results. Alizée services the following areas of preclinical medicine and science: bone repair, interventional medicine, oncology, inflammatory diseases, immunotherapy, regenerative medicine, surgical tools, pharmaceuticals and tissue phenotyping. Included among its staff are 4 board-certified (ACVP) Veterinary Pathologists, more than 20 highly trained histology technicians and scientists and a dedicated Quality Assurance (QA) unit. The entire team is committed to the highest quality work and excellent customer service. Additional information about Alizée is available at http://www.alizeepathology.com.

About Ampersand Capital Partners

Founded in 1988, Ampersand is a middle market private equity firm dedicated to growth-oriented investments in the healthcare sector. With offices in Boston, MA and Amsterdam, Netherlands, Ampersand leverages a unique blend of private equity and operating experience to build value and drive superior long-term performance alongside its portfolio company management teams. Ampersand has helped build numerous market-leading companies across each of its core healthcare sectors, including Brammer Bio, Confluent Medical, Genewiz, Genoptix, Talecris Biotherapeutics and Viracor-IBT Laboratories. Additional information about Ampersand is available at http://www.ampersandcapital.com.

Share article on social media or email:

Home and Family: Marriage / Relationships

Travel & Adventure Show Returns to San Diego Convention Center January 18 and 19, 2020 with Celebrity Guest Speakers Cheryl Strayed, Wayne Dunlap, and Peter Greenberg

Leave a comment


News Image

As America’s Favorite Travel Show, we are bringing travel tips from experts around the world, exquisite traditional song and dance performances from multiple countries, and travel deals only offered exclusively at the Travel & Adventure Show.


SAN DIEGO, Calif. (PRWEB)

The Travel & Adventure Show is excited to announce its return to San Diego on Saturday and Sunday, January 18th and 19th, 2020 at the San Diego Convention Center. The nation’s largest travel show will feature exhibitors from more than 200 global travel destinations, thousands of travel experts to help guests plan trips, and exclusive show-only travel deals for guests to take advantage of.

“If you’ve had a trip in mind or looking for your next adventure, The Travel & Adventure Show is the ultimate place to uncover your next destination,” said John Golicz, CEO, Unicomm, LLC. “As America’s Favorite Travel Show, we are bringing travel tips from experts around the world, exquisite traditional song and dance performances from multiple countries, and travel deals only offered exclusively at the Travel & Adventure Show.”

The San Diego Travel & Adventure Show will feature presentations by travel experts and celebrity travel personalities, offering guests a wealth of knowledge regarding tech travel hacks and much more. Speakers currently scheduled to present at the Travel Theater will include:

  • Cheryl Strayed, Author of the New York Times Bestselling Memoir “Wild”

  • Peter Greenberg, Emmy Award-Winning Investigative Reporter and Producer and CBS News Travel Editor

  • Patricia Schultz, Author of the New York Times Bestseller “1,000 Places to See Before You Die”

  • Wayne Dunlap, Author of Plan Your Escape and TripAdvisor Top 25 Travel Blogger


Attending the San Diego Travel & Adventure Show is packed with activities for attendees. Guests can get their pictures taken in their favorite destination at the Visit Redding Green Screen, Segway, Coconut Climb, National Parks’ ParkTracks,

Attendees will be able to take in travel tips at multiple stages including:

  • Savvy Traveler Theater Stage—visitors will interact with travel experts on subjects ranging from packing and travel technology, to maximizing credit card reward points and what to do if disaster strikes while traveling.

  • Destination Theater— travelers will receive destination-specific information from local experts tied to travel best practices like when to go, how to get there, what to see, and off-the-beaten-path attractions from destinations such as Alaska, Taiwan, India, and Tahiti, among others.

  • Global Beats Stage— attendees can feel the beat and experience the rhythm of cultural dances and performances during the 20+ presentations slated to take place throughout the weekend.


MSC Cruises is the event’s Major Sponsor, while Taiwan Tourism is the Supporting Sponsor. Contributing Sponsors include Cruise Planners and American Express Travel Company. Add in Passport

The San Diego Travel & Adventure Show will take place on January 18th and 19th at the San Diego Convention Center. The show opens at 9:30 a.m. Saturday for travel professionals; the public can attend from 10 a.m. to 5 p.m. Saturday and from 11 a.m. to 4 p.m. on Sunday. Attendees can purchase single-day and two-day tickets online now for the discounted rate of $12/$19 for a limited time only or on-site for $15/$22. Children 16 and under are free and on-site tickets can be purchased with cash only. For tickets and additional event information, visit http://travelshows.com/san-diego and use promo code SDPR20 to receive $11 tickets.

About Unicomm, LLC and the Travel & Adventure Show Series

UNICOMM LLC is an independent business-to-business communications company specializing in originating and managing world-class trade shows and conferences. Unicomm’s properties include the nation’s largest and longest running series of travel events, the Travel & Adventure Show in Washington, D.C., Chicago, San Francisco/Bay Area, Los Angeles, San Diego, Denver, Philadelphia, Dallas, Boston and Atlanta, which is new in 2020.

Share article on social media or email:

Health: Mental Health

Into the Summit for Mental Health and Wellness 2019 – A Caving Expedition to Raise Funds to Support Canadian Veterans and their Families

Leave a comment



CALGARY, Alberta (PRWEB)

The Third Annual Into the Summit for Mental Health and Wellness fundraising initiative is coming up this weekend. Organized by the Princess Patricia’s Canadian Light Infantry (PPCLI) Foundation in partnership with Canmore Cave Tours, this year a team of volunteers, members of the military and caving experts will descent into Rat’s Nest Cave – to heighten awareness and raise funds for veterans and their families suffering for the devastating consequences of PTSD and other forms of mental illness.

On Sunday November 10, 2019, campaign participants will venture into the Rat’s Nest Cave – a wild, undeveloped cave under Grotto Mountain near Canmore, Alberta. Formally recognized as one of Canada’s Historic Places in 1987, the cave was once home to a rich variety of animal species. At over 4km long, Rat’s Nest is one of the longest caves in Canada. Exploring this cave involves climbing, crawling, sliding, wiggling and squeezing through water-worn passages past ancient cave formations and bones.

All of the 32 participants are raising funds to join this adventure. Proceeds will be used to fund non-clinical therapies for military veterans and their families. Over $125,000 was raised from the 2016 and 2017 campaigns – during which participants climbed to the summits of Mount Buller and Mount Farquhar in Kananaskis County. For further information, to register as a caver, or to donate to someone already registered, please visit:

https://www.canmorecavetours.com/into-the-summit

ABOUT THE PPCLI FOUNDATION

For more than 100 years, soldiers of the Princess Patricia Canadian Light Infantry have been serving Canadians with honour and distinction. The PPCLI Foundation was founded to ensure that legacy of our proud military history lives on in future generations. The Foundation serves the needs of the families of our fallen soldiers and veterans and their families, especially those who have suffered as a result of their service to Canada and Canadians.

ABOUT CANMORE CAVES

Canmore Cave Tours offers year-round, rain or shine, caving experiences in Rat’s Nest Cave – a wild, undeveloped cave under Grotto Mountain. Located near Banff and Canmore in the beautiful Canadian Rockies the cave is one of the longest caves in Canada. The company’s tours of the Rat’s Nest Cave include a mix of adventure, education, physical and psychological challenge, and just pure fun.

Share article on social media or email:

Business: Executives

ELM Resources Celebrates 25 Years in the Student Lending Industry

Leave a comment


ELM Resources – 25 Years

We have built an exceptional team that is never satisfied with the status quo. We look forward to continuing to find ways to improve and further delight our customers.


TAMPA, Fla. (PRWEB)

ELM Resources, the leading provider of private student loan management and services for college and university campuses, celebrates its 25th anniversary this week in the student lending industry. ELM was founded in 1994 as a not-for-profit, mutual benefit corporation to provide a common, non-proprietary and open data exchange and disbursement system that seamlessly links the diverse computing platforms of schools and lenders. ELM has seen many changes in the industry over the past twenty-five years and has successfully evolved while remaining true to its mission as a not-for-profit for the industry it serves.

This major milestone comes after the completion of the most recent private loan peak processing season during which ELM processed record private loan volumes via its industry leading product suite, ELMOne. This success was driven by providing consistency in ELM’s service and stability in its systems. ELM’s focus is always on its customers and team members. ELM’s customer service, as measured through its annual School Satisfaction Survey, has been in the 95th percentile or above for the last nine years. And, ELM Resources is a certified “Great Place to Work®” by the independent analysts at Great Place to Work® and ranked #21 on the 2019 Fortune Magazine list of “Best Small Workplaces”.

“For a quarter of a century, ELM has been focused on providing the highest quality products and services to our school and lender customers within the student loan industry,” says Phillip Wade, ELM’s Chief Executive Officer and President. “As we celebrate and appreciate all that has been accomplished in the last 25 years, we also look to what can be achieved during the next 25 years. As always, we will focus on our core principles – remaining open and lender-neutral, providing exceptional customer service, and striving for continuous improvement. We have built an exceptional team that is never satisfied with the status quo. We look forward to continuing to find ways to improve and further delight our customers.”

About ELM Resources:

ELM Resources was founded in 1994 and is the only not-for-profit mutual benefit corporation serving the student loan industry today, including universities, colleges and lenders. ELM provides a common, non-proprietary and open data exchange and disbursement system that seamlessly links the diverse computing platforms of schools and lenders through its industry leading product, ELMOne. Within the ELMOne suite, ELMSelect®, ELMNet® and ELM NDN® each provide unparalleled efficiency in handling different phases of the private student loan process, such as financial fundamentals, lender comparison, loan application, school certification and loan disbursement processes. Over 1,800 campuses use ELM Resources to send and receive loan data for alternative loans with the lender of their choice. ELM Resources is a certified “Great Place to Work®” by the independent analysts at Great Place to Work® and ranked #21 on the most recent Fortune Magazine list of “Best Small Workplaces”.

Share article on social media or email: